This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Johnson & Johnson (JNJ)

NYSE: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 13.73B 14.52B 20.93B 14.91B
Receivables 10.73B 10.98B 11.71B 11.31B
Inventories 8.05B 8.18B 7.88B 7.50B
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 60.21B 59.31B 56.41B 46.12B
Property, Plant & Equipment, Gross 36.65B 36.69B 37.13B 34.65B
Accumulated Depreciation & Depletion 20.74B 20.56B 20.42B 18.56B
Property, Plant & Equipment, Net 15.90B 16.13B 16.71B 16.10B
Intangibles 25.76B 27.22B 27.95B 28.75B
Other Non-Current Assets 4.41B 3.23B 4.95B 3.42B
Total Non-Current Assets 73.20B 71.81B 76.28B 75.23B
Liabilities & Shareholder Equity
Total Assets 133.41B 131.12B 132.68B 121.35B
Accounts Payable 6.67B 7.63B 6.27B 5.83B
Short Term Debt 7.00B 3.64B 4.85B 4.68B
Other Current Liabilities 750.00M 500.00M 770.00M 1.06B
Total Current Liabilities 27.75B 25.09B 25.68B 24.26B
Long Term Debt 12.86B 15.12B 13.33B 11.49B
Deferred Income Taxes 2.56B 3.15B 3.99B 3.14B
Other Non-Current Liabilities 19.09B 18.01B 15.64B 17.63B
Minority Interest 0.00 0.00 0.00 -339.00M
Total Non-Current Liabilities 34.51B 36.28B 32.95B 32.26B
Total Liabilities 62.26B 61.37B 58.63B 56.52B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 71.15B 69.75B 74.05B 64.83B
Common Par 3.12B 3.12B 3.12B 3.12B
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 103.88B 97.25B 89.49B 85.99B
Treasury Stock -22.68B -19.89B -15.70B -18.48B
Other Equity Adjustments -13.16B -10.72B -2.86B -5.81B
Total Capitalization 84.01B 84.87B 87.38B 76.31B
Total Equity 71.15B 69.75B 74.05B 64.83B
Total Liabilities & Stock Equity 133.41B 131.12B 132.68B 121.35B
Total Common Shares Outstanding 2.76B 2.78B 2.82B 2.80B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 364.68M 336.62M 299.21M 341.35M
Basic Weighted Shares Outstanding 2.77B 2.82B 2.81B 2.75B
Diluted Weighted Shares Outstanding 2.81B 2.86B 2.88B 2.81B
Number of Employees 127100 126500 128100 127600
Number of Part-Time Employees 0 0 0 0
JNJ News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

JNJ Johnson & Johnson

Chart of JNJ

Analysts Ratings for JNJ

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 7 7
Moderate Buy 2 1 1 1
Hold 7 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
GET JNJ ANALYST REPORT

JNJ Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs